Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $151.3100 (1.19%) ($148.6100 - $151.3900) on Fri. Feb. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.06% (three month average) | RSI | 64 | Latest Price | $151.3100(1.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) IBB(21%) XLV(17%) XOP(17%) XBI(16%) XLE(15%) | Factors Impacting ABBV price | ABBV will decline at least -0.53% in a week (0% probabilities). XLC(-15%) IPO(-11%) VXX(-8%) BWX(-8%) XLK(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.53% (StdDev 1.06%) | Hourly BBV | 0.5 () | Intraday Trend | 1.4% | | | |
|
5 Day Moving Average | $151.64(-0.22%) | 10 Day Moving Average | $149.52(1.2%) | 20 Day Moving Average | $148.17(2.12%) | To recent high | -9.2% | To recent low | 4.6% | Market Cap | $266.954b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |